Can VEGF be used in differential diagnosis of pleural effusions? Source: Eur Respir J 2007; 30: Suppl. 51, 565s Year: 2007
The value of adenosin-deaminase in etiologic diagnosis of pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 167s Year: 2002
The diagnostic role of pleural fluid and serum Pentraxin-3 levels in the determination of the etiology of pleural effusion Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017
The role of thoracoscopy in the diagnosis of malignant pleural effusions (PE) Source: Eur Respir J 2002; 20: Suppl. 38, 438s Year: 2002
Importance of complement C3-C4 levels on differential diagnosis of pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 688s Year: 2005
Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012
Diagnostic significance of interferon-gamma level in tuberculous pleural effusions Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007
Pleural fluid leptin level for the differential diagnosis of pleural effusion Source: Eur Respir J 2006; 28: Suppl. 50, 343s Year: 2006
Use of carcinoembryonic antigen in pleural effusion for differential diagnosis of benign and malignant pleural effusion Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008
Pleural fluid interleukin-10 level in the diagnosis of tuberculous effusions Source: Eur Respir J 2002; 20: Suppl. 38, 581s Year: 2002
The Role of PET-CT in differential diagnosis of malignant-paramalignant pleural effusion Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018
Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 775s Year: 2006
Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019
Role of C-reactive protein in discriminating complicated and uncomplicated parapneumonic effusion from malignant and tuberculous pleural effusion Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status Year: 2021
Diagnostic usefulness of C reactive protein levels in pleural effusions of malignant and non malignant origin Source: Eur Respir J 2007; 30: Suppl. 51, 431s Year: 2007
Investigating unilateral pleural effusions: the role of cytology Source: Eur Respir J, 52 (5) 1801254; 10.1183/13993003.01254-2018 Year: 2018
Diagnostic value of combined assays in differentiating tuberculous and malignant pleural effusions Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
Investigating unilateral pleural effusions: the role of cytology. Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018
Prognostic significance of neutrophil predominance in pleural fluid in patients with malignant effusion Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010
Clinical and laboratorial variables useful in the differential diagnosis of pleural effusions secondary to tuberculosis or lymphoma Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011